Iovance Biotherapeutics (IOVA) Analyst Estimates Quarterly - Discounting Cash Flows
Iovance Biotherapeutics, Inc.
IOVA (NASDAQ)

* (except for per share items) of USD
Period Ending: 2026
12-31
2026
09-30
2026
06-30
2026
03-31
2025
12-31
2025
09-30
2025
06-30
2025
03-31
2024
12-31
2024
09-30
2024
06-30
2024
03-31
2023
12-31
2023
09-30
2023
06-30
2023
03-31
Number of Analysts
1234
6 9 4 6 4 8 4 6 4
Estimated Revenue
Low
1234
75.8 69.8 53.8 24.6 2.01 0.56 4.50 3.91 0.20
Average
1234
81.5 72.1 53.8 24.6 2.03 1.44 4.50 3.91 0.22
High
1234
86.9 77.9 53.8 24.6 2.05 2.31 4.50 3.91 0.27
Estimated EBITDA
Low
1234
15.2 14.0 10.8 4.92 0.40 0.11 0.90 0.78 0.04
Average
1234
16.3 14.4 10.8 4.92 0.41 0.29 0.90 0.78 0.04
High
1234
17.4 15.6 10.8 4.92 0.41 0.46 0.90 0.78 0.05
Estimated EBIT
Low
1234
15.2 14.0 10.8 4.92 0.40 0.11 0.90 0.78 0.04
Average
1234
16.3 14.4 10.8 4.92 0.41 0.29 0.90 0.78 0.04
High
1234
17.4 15.6 10.8 4.92 0.41 0.46 0.90 0.78 0.05
Estimated Net Income
Low
1234
-82.6 -86.2 -86.6 -102 -123 -133 -132 -144 -214
Average
1234
-69.3 -77.6 -86.6 -102 -123 -125 -132 -144 -164
High
1234
-58.6 -71.9 -86.6 -102 -123 -114 -132 -144 -142
Estimated SGA Expenses
Low
1234
1,422 1,311 1,009 462 37.7 10.6 84.5 73.4 3.74
Average
1234
1,530 1,354 1,010 462 38.1 27.0 84.5 73.4 4.17
High
1234
1,631 1,462 1,010 462 38.5 43.3 84.5 73.4 5.15
Estimated EPS
Low
1234
-0.285 -0.297 -0.299 -0.353 -0.424 -0.460 -0.455 -0.498 -0.740
Average
1234
-0.239 -0.268 -0.299 -0.353 -0.424 -0.431 -0.455 -0.498 -0.567
High
1234
-0.202 -0.248 -0.299 -0.353 -0.424 -0.392 -0.455 -0.498 -0.491
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us